Skip to content

Wide Diameter Bone Anchored Implant Study

A Clinical Study of the Oticon Medical Ponto 4.5mm Wide Implant

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01671176
Enrollment
30
Registered
2012-08-23
Start date
2012-05-31
Completion date
2014-11-30
Last updated
2018-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Conductive and Sensori-neural Hearing Loss in the Same Ear, Conductive Hearing Loss, Unilateral, Profound Sensori-neural Hearing Loss

Keywords

Wide diameter implant, ISQ, Ponto, Bone anchored implant

Brief summary

To assess implant stability, implant loss, adverse skin reactions, and Quality of Life Benefit following implantation of the Ponto 4.5mm Wide Diameter implant. Secondary: to determine the feasibility of fitting the sound processor 3 weeks after surgical implantation, and to investigate if the type of skin reactions following implantation could be related to the demographic data of subjects and the type of surgical technique used

Detailed description

Bone-anchored hearing systems have been an amplification choice for conductive, mixed, and profound, unilateral, sensorineural hearing loss for over three decades. So far, about 75,000 patients worldwide have received this surgical intervention (bone-anchored hearing system), since its first successful implantation in 1977. In 2009, Oticon Medical, LLC launched its bone-anchored hearing system called Ponto. In just over two years, the Ponto has been successfully implanted in over 3,000 patients by leading otolaryngologists and neurotologists in 18 countries worldwide. The Ponto implant has previously been available with a 3.75mm diameter and comes in two lengths: 3mm and 4mm. Anew Ponto implant that is 4.5mm wide in diameter is now available in both 3mm and 4mm lengths. This Wide Diameter implant is designed to maximize bone-to-implant contact area and enhance implant stability which can potentially allow loading of the sound processor as early as 3 weeks after surgery. The abutment screw incorporates external threads at the screw head to make it possible to connect a SmartPeg (Osstell, Goteborg, Sweden) for stability measurements. All Ponto implants have the same universal implant-abutment interface. Therefore, they are fully compatible with existing instruments and abutments. Two new countersinks have been developed for the new Ponto Wide Diameter implant. The drill size of the countersink is 3.80mm. It is marked with a W to separate them from existing drills. All products are CE-marked and cleared for the US market by the FDA. Objectives The present study will attempt to show that the Ponto 4.5mm Wide Diameter implant has similar or better outcomes in terms of Quality of Life (QoL) benefit; implant extrusion and revision surgery when compared to the 3.75mm diameter implant. Secondary objectives to be studied will include adverse skin reactions, the feasibility of fitting the sound processor three weeks after surgical implantation, and investigation to see if the type of skin reactions observed following implantation could be related to the demographic data of subjects or the type of surgical technique used. Study Design This study is a prospective, multicenter study of subjects' demographic and implant data. Subjects will be enrolled at two US sites. Subject Population Twenty adult subjects 18 years or older will be included in the study from each participating partner site.

Interventions

DEVICEWide diameter bone anchored implant

4.5 mm wide diameter bone anchored implant

Sponsors

Oticon Medical
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* conductive, mixed or single sided deafness * 18 years of age or older

Exclusion criteria

* younger than 18 years of age

Design outcomes

Primary

MeasureTime frameDescription
Holger's Scale1 week, 3 weeks, 6 weeks, 3 months, 6 months and 12 monthsHolger's Scale is a 5 point that ranges from 0 - 4 scale that assesses skin reactions at the implant site where 0 means no reaction and 4 means excessive granulation, skin overgrowth, or scar formation requiring revision surgery
Implant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal PlaneAt surgery, 1 week, 3 weeks, 6 weeks, 12 weeks, 6 months and 12 monthsPresently, the recommendations to load the sound processor on a bone anchored implant is 3 months (for adults). Using outcome measures, i.e., OSSTELL ISQ ranges from 0 -100 where 0 is least stable and 100 being the most stable.

Countries

United States

Participant flow

Participants by arm

ArmCount
Wide Diameter Bone Anchored Implant
Intervention: Implantation of a wide diameter bone anchored auditory implant either 3 or 4 mm in length, into the skull on the side of the ear where intervention is intended in order to restore hearing. In the case of a conductive or mixed hearing loss, that side is chosen. In patients with unilateral, profound sensori-neural hearing loss the implant is implanted on that side but the sound is transmitted to the side with the normal hearing ear via bone conduction stimulation. Wide diameter bone anchored implant: 4.5 mm wide diameter bone anchored implant
30
Total30

Baseline characteristics

CharacteristicWide Diameter Bone Anchored Implant
Abutment length
12 mm
3 participants
Abutment length
6 mm
20 participants
Abutment length
9 mm
7 participants
Age, Continuous60.83 years
STANDARD_DEVIATION 16.07
BMI28.56 kilogram/M^2
STANDARD_DEVIATION 7.09
Diabetes
no
27 participants
Diabetes
yes
3 participants
Height163.79 centimeters
STANDARD_DEVIATION 8.89
Region of Enrollment
United States
30 participants
Sex: Female, Male
Female
22 Participants
Sex: Female, Male
Male
8 Participants
Smoking status
no
29 participants
Smoking status
yes
1 participants
Weight76.72 kilogram
STANDARD_DEVIATION 19.61

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 30
serious
Total, serious adverse events
1 / 30

Outcome results

Primary

Holger's Scale

Holger's Scale is a 5 point that ranges from 0 - 4 scale that assesses skin reactions at the implant site where 0 means no reaction and 4 means excessive granulation, skin overgrowth, or scar formation requiring revision surgery

Time frame: 1 week, 3 weeks, 6 weeks, 3 months, 6 months and 12 months

ArmMeasureGroupValue (NUMBER)
Wide Diameter Bone Anchored ImplantHolger's ScaleHolger score 0 at 1 week29 participants
Wide Diameter Bone Anchored ImplantHolger's ScaleHolger score of 1 at one week0 participants
Wide Diameter Bone Anchored ImplantHolger's ScaleHolger score of 2 at one week1 participants
Wide Diameter Bone Anchored ImplantHolger's ScaleHolger score of 0 at 3 weeks29 participants
Wide Diameter Bone Anchored ImplantHolger's ScaleHolger score of 1 at 3 weeks1 participants
Wide Diameter Bone Anchored ImplantHolger's ScaleHolger score of 2 at 3 weeks0 participants
Wide Diameter Bone Anchored ImplantHolger's ScaleHolger score of 0 at 6 weeks28 participants
Wide Diameter Bone Anchored ImplantHolger's ScaleHolger score of 1 at 6 weeks2 participants
Wide Diameter Bone Anchored ImplantHolger's ScaleHolger score of 2 at 6 weeks0 participants
Wide Diameter Bone Anchored ImplantHolger's ScaleHolger score of 0 at 3 months29 participants
Wide Diameter Bone Anchored ImplantHolger's ScaleHolger score of 1 at 3 months1 participants
Wide Diameter Bone Anchored ImplantHolger's ScaleHolger score of 2 at 3 months0 participants
Wide Diameter Bone Anchored ImplantHolger's ScaleHolger score of 0 at 6 months30 participants
Wide Diameter Bone Anchored ImplantHolger's ScaleHolger score of 1 at 6 months0 participants
Wide Diameter Bone Anchored ImplantHolger's ScaleHolger score of 2 at 6 months0 participants
Wide Diameter Bone Anchored ImplantHolger's ScaleHolger score of 0 at 12 months29 participants
Wide Diameter Bone Anchored ImplantHolger's Scaleolger score of 1 at 12 months 11 participants
Wide Diameter Bone Anchored ImplantHolger's ScaleHolger score of 2 at 12 months0 participants
Primary

Implant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal Plane

Presently, the recommendations to load the sound processor on a bone anchored implant is 3 months (for adults). Using outcome measures, i.e., OSSTELL ISQ ranges from 0 -100 where 0 is least stable and 100 being the most stable.

Time frame: At surgery, 1 week, 3 weeks, 6 weeks, 12 weeks, 6 months and 12 months

ArmMeasureGroupValue (MEAN)Dispersion
Wide Diameter Bone Anchored ImplantImplant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal PlaneISQ vertical at surgery58.43 units on a scaleStandard Deviation 8.01
Wide Diameter Bone Anchored ImplantImplant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal PlaneISQ horizontal at surgery58.58 units on a scaleStandard Deviation 7.42
Wide Diameter Bone Anchored ImplantImplant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal PlaneISQ vertical at one week59.70 units on a scaleStandard Deviation 7.03
Wide Diameter Bone Anchored ImplantImplant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal PlaneISQ horizontal at one week59.77 units on a scaleStandard Deviation 7.88
Wide Diameter Bone Anchored ImplantImplant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal PlaneISQ vertical at 3 weeks60.53 units on a scaleStandard Deviation 7.14
Wide Diameter Bone Anchored ImplantImplant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal PlaneISQ horizontal at 3 weeks60.30 units on a scaleStandard Deviation 7.78
Wide Diameter Bone Anchored ImplantImplant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal PlaneISQ vertical at 6 weeks61.28 units on a scaleStandard Deviation 5.81
Wide Diameter Bone Anchored ImplantImplant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal PlaneISQ horizontal at 6 weeks61.02 units on a scaleStandard Deviation 6.56
Wide Diameter Bone Anchored ImplantImplant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal PlaneISQ vertical at 12 weeks61.97 units on a scaleStandard Deviation 5.91
Wide Diameter Bone Anchored ImplantImplant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal PlaneISQ horizontal at 12 weeks62.00 units on a scaleStandard Deviation 6.07
Wide Diameter Bone Anchored ImplantImplant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal PlaneISQ vertical at 6 month63.62 units on a scaleStandard Deviation 5.26
Wide Diameter Bone Anchored ImplantImplant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal PlaneISQ horizontal at 6 months63.27 units on a scaleStandard Deviation 5.48
Wide Diameter Bone Anchored ImplantImplant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal PlaneISQ vertical at 12 months63.73 units on a scaleStandard Deviation 5.31
Wide Diameter Bone Anchored ImplantImplant Stability as Measured by the Osstell Implant Stability Quotient in the Vertical and Horizontal PlaneISQ horizontal at 12 months63.62 units on a scaleStandard Deviation 5.26

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026